HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mei-Chen Hu Selected Research

N-nitrosoiminodiacetic acid

10/2019Understanding site variability in a multisite clinical trial of a technology-delivered psychosocial intervention for substance use disorders.
1/2017Sociodemographic and Substance Use Disorder Determinants of HIV Sexual Risk Behavior in Men and Women in Outpatient Drug Treatment in the NIDA National Drug Abuse Treatment Clinical Trials Network.
6/2015Gender-based Outcomes and Acceptability of a Computer-assisted Psychosocial Intervention for Substance Use Disorders.
4/2014Clinically relevant characteristics associated with early treatment drug use versus abstinence.
1/2014Associations between post-traumatic stress symptoms, stimulant use, and treatment outcomes: a secondary analysis of NIDA's Women and Trauma study.
5/2012Helping alliance, retention, and treatment outcomes: a secondary analysis from the NIDA Clinical Trials Network Women and Trauma Study.
9/2011Zero-inflated and hurdle models of count data with extra zeros: examples from an HIV-risk reduction intervention trial.
9/2010The role of alcohol misuse in PTSD outcomes for women in community treatment: a secondary analysis of NIDA's Women and Trauma Study.
4/2010The impact of trauma-focused group therapy upon HIV sexual risk behaviors in the NIDA Clinical Trials Network "Women and trauma" multi-site study.
8/2008Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mei-Chen Hu Research Topics

Disease

18Substance-Related Disorders (Drug Abuse)
10/2019 - 08/2008
9Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
11/2019 - 07/2010
7Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2017 - 01/2010
6Wounds and Injuries (Trauma)
01/2017 - 04/2010
5Tobacco Use Disorder (Nicotine Dependence)
10/2013 - 04/2007
3Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/2018 - 07/2010
2Opioid-Related Disorders (Opiate Addiction)
01/2022 - 01/2017
2Marijuana Use
01/2019 - 01/2018
2Mental Disorders (Mental Disorder)
01/2017 - 05/2011
2Alcoholism (Alcohol Abuse)
04/2015 - 04/2014
2Acquired Immunodeficiency Syndrome (AIDS)
09/2011 - 08/2008
1Pain (Aches)
01/2019
1Cognitive Dysfunction
03/2018
1Cocaine-Related Disorders (Cocaine Addiction)
11/2017
1Borderline Personality Disorder (Personality Disorders, Borderline)
01/2017

Drug/Important Bio-Agent (IBA)

10N-nitrosoiminodiacetic acidIBA
10/2019 - 08/2008
8Methylphenidate (Ritalin)FDA LinkGeneric
11/2019 - 07/2010
7Pharmaceutical PreparationsIBA
01/2017 - 08/2008
5Cocaine (Cocaine HCl)IBA
03/2018 - 04/2014
5NicotineFDA Link
01/2018 - 04/2007
4Opioid Analgesics (Opioids)IBA
01/2022 - 04/2014
2TESIBA
01/2018 - 05/2015
2Sertraline (Zoloft)FDA LinkGeneric
10/2016 - 04/2015
2Carbon MonoxideIBA
06/2015 - 10/2013
2SmokeIBA
08/2012 - 07/2010
2Methadone (Dolophine)FDA LinkGeneric
01/2009 - 01/2009
1Naltrexone (ReVia)FDA LinkGeneric
01/2022
1Heroin (Diamorphine)IBA
01/2019
1BenzodiazepinesIBA
01/2019
1Biological ProductsIBA
11/2017
15,6-dihydroxy-2-dimethylaminotetralin (M 7)IBA
04/2015
1trans-crotonin (CTN)IBA
04/2014
1Illicit Drugs (Recreational Drugs)IBA
05/2011

Therapy/Procedure

5Tobacco Use Cessation Devices
12/2015 - 07/2010
1Injections
01/2022
1Female Condoms (Female Condom)
08/2011
1Self Medication
01/2010